Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
Vermeire, Séverine, Prof, Schreiber, Stefan, Prof, Petryka, Robert, MD, Kuehbacher, Tanja, Prof, Hebuterne, Xavier, Prof, Roblin, Xavier, MD, Klopocka, Maria, PhD, Goldis, Adrian, MD, Wisniewska-Jarosinska, Maria, MD, Baranovsky, Andrey, Prof, Sike, Robert, MD, Stoyanova, Kremena, MD, Tasset, Chantal, PhD, Van der Aa, Annegret, PhD, Harrison, Pille, DPhil
Published in The Lancet (British edition) (21.01.2017)
Published in The Lancet (British edition) (21.01.2017)
Get full text
Journal Article
Does Body Mass Index associate with the endoscopic severity of gastroesophageal reflux disease?
Tóth, Tamás G., Demeter, Pál, Sike, Róbert, Pap, Ákos
Published in Dubai diabetes and endocrinology journal (01.03.2019)
Published in Dubai diabetes and endocrinology journal (01.03.2019)
Get full text
Journal Article
Su1930 - Maintenance of Clinical Effect in Patients with Moderate-to-Severe Crohn’s Disease Treated with Filgotinib, a Selective jak1 Inhibitor: Exploratory 20-Week Data Analysis of the Phase 2 Fitzroy Study
Vermeire, Severine, Schreiber, Stefan, Petryka, Robert, Kuehbacher, Tanja, Hebuterne, Xavier, Roblin, Xavier, Klopocka, Maria, Goldis, Adrian, Wisniewska-Jarosinska, Maria A., Baranovsky, Andrei, Sike, Robert, Stoyanova, Kremena, Meuleners, Luc, Tasset, Chantal T., Van der Aa, Annegret, Harrison, Pille
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Get full text
Journal Article
Su1920 - Efficacy of Filgotinib, a Selective jak1 Inhibitor, is Independent of Prior Anti-TNF Exposure: Subgroup Analysis of the Phase 2 Fitzroy Study in Moderate-To-Severe Crohn’s Disease
D'Haens, Geert R., Schreiber, Stefan, Petryka, Robert, Kuehbacher, Tanja, Hebuterne, Xavier, Roblin, Xavier, Klopocka, Maria, Goldis, Adrian, Wisniewska-Jarosinska, Maria A., Baranovsky, Andrei, Sike, Robert, Stoyanova, Kremena, Meuleners, Luc, Tasset, Chantal T., Van der Aa, Annegret, Harrison, Pille, Vermeire, Severine
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Get full text
Journal Article
Maintenance of Clinical Effect in Patients with Moderate-to-Severe Crohn’s Disease Treated with Filgotinib, a Selective jak1 Inhibitor: Exploratory 20-Week Data Analysis of the Phase 2 Fitzroy Study
Vermeire, Severine, Schreiber, Stefan, Petryka, Robert, Kuehbacher, Tanja, Hebuterne, Xavier, Roblin, Xavier, Klopocka, Maria, Goldis, Adrian, Wisniewska-Jarosinska, Maria A., Baranovsky, Andrei, Sike, Robert, Stoyanova, Kremena, Meuleners, Luc, Tasset, Chantal T., Van der Aa, Annegret, Harrison, Pille
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Get full text
Journal Article
Maintenance of Clinical Effect in Patients with Moderateto-Severe Crohn’s Disease Treated with Filgotinib, a Selective jak1 Inhibitor: Exploratory 20-Week Data Analysis of the Phase 2 Fitzroy Study
Vermeire, Severine, Schreiber, Stefan, Petryka, Robert, Kuehbacher, Tanja, Hebuterne, Xavier, Roblin, Xavier, Klopocka, Maria, Goldis, Adrian, Wisniewska-Jarosinska, Maria A, Baranovsky, Andrei, Sike, Robert, Stoyanova, Kremena, Meuleners, Luc, Tasset, Chantal T, Van der Aa, Annegret, Harrison, Pille
Published in Gastroenterology (New York, N.Y. 1943) (2017)
Published in Gastroenterology (New York, N.Y. 1943) (2017)
Get full text
Journal Article
812c Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor, Induces Clinical Remission in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 2 FITZROY Study Interim Analysis
Vermeire, Severine, Schreiber, Stefan, Petryka, Robert, Kuehbacher, Tanja, Hebuterne, Xavier, Roblin, Xavier, Klopocka, Maria, Goldis, Adrian, Wisniewska-Jarosinska, Maria A, Baranovsky, Andrei, Sike, Robert, Tasset, Chantal T, Van der Aa, Annegret, Harrison, Pille
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2016)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2016)
Get full text
Journal Article
Efficacy of Filgotinib, a Selective jak1 Inhibitor, is Independent of Prior Anti-TNF Exposure: Subgroup Analysis of the Phase 2 Fitzroy Study in Moderate-To-Severe Crohn’s Disease
D'Haens, Geert R, Schreiber, Stefan, Petryka, Robert, Kuehbacher, Tanja, Hebuterne, Xavier, Roblin, Xavier, Klopocka, Maria, Goldis, Adrian, Wisniewska-Jarosinska, Maria A, Baranovsky, Andrei, Sike, Robert, Stoyanova, Kremena, Meuleners, Luc, Tasset, Chantal T, Van der Aa, Annegret, Harrison, Pille, Vermeire, Severine
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Get full text
Journal Article
Severity of gastroesophageal reflux disease influences daytime somnolence: a clinical study of 134 patients underwent upper panendoscopy
Demeter, Pál, Visy, Katalin-Várdi, Gyulai, Norá, Sike, Róbert, Tóth, Tamás G, Novák, János, Magyar, Pál
Published in World journal of gastroenterology : WJG (15.06.2004)
Published in World journal of gastroenterology : WJG (15.06.2004)
Get full text
Journal Article
Comparison of the effectiveness and tolerability of the saccharosum-sennosid-B solution and sodium-picosulfate in preparation for colonoscopy. Prospective, multicenter, randomized study
Demeter, Pál, Ujszászy, László, Sike, Róbert, Tóth, G Tamás, Grenda, Andor, Kiss, Gyula G, Novák, János, Gurzó, Zoltán, Csiki, Zoltán
Published in Orvosi hetilap (10.08.2003)
Get more information
Published in Orvosi hetilap (10.08.2003)
Journal Article